How does awaiting third-party approval affect the completeness of an invention?

Awaiting approval from a third-party organization, such as Underwriters’ Laboratories, typically does not extend the experimental use period if the inventor already considers the invention complete. The MPEP states: If the examiner concludes from the evidence of record that the inventor was satisfied that an invention was in fact “complete,” awaiting approval by the inventor…

Read More

How does supplemental examination affect patent enforceability?

Supplemental examination can have a significant impact on patent enforceability. According to the MPEP: “35 U.S.C. 257(c) specifies the effect of a supplemental examination under 35 U.S.C. 257(a) and any resulting ex parte reexamination under 35 U.S.C. 257(b) on the enforceability of the patent.” Generally, if information is considered, reconsidered, or corrected during supplemental examination,…

Read More

What constitutes sufficient evidence of reduction to practice in patent law?

Sufficient evidence of reduction to practice is crucial in patent law, especially when establishing priority or defending against challenges. The MPEP 2138.05 provides guidance on what constitutes adequate evidence: “In order to establish an actual reduction to practice, the inventor must prove that: (1) he or she constructed an embodiment or performed a process that…

Read More